Recent Drug Discovery Research for February 2025
Angina (Angina Pectoris) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Cardiovascular
| Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, CNS/Neurology
| Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Pain, Arthritis, Osteoporosis, Drug Discovery
| Binge Eating Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Obesity, Drug Discovery
| Acne Vulgaris Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Rosacea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Vitiligo Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Dermatology
| Polycystic Kidney Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Renal
| Overactive Bladder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Acinetobacter Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Haemophilus Influenzae Type B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Influenza, Drug Discovery
| Neisseria Meningitidis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Clostridioides Difficile Infections (Clostridium Difficile Associated Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Gastrointestinal
| Japanese Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Yellow Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Melanocortin Receptor 4 (MC4R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery
| Hepatitis A Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Hepatitis, Drug Discovery
| Osteoporosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Osteoporosis, Drug Discovery, Clinical Trial
| Inclusion Body Myositis (IBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Essential Thrombocythemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Pheochromocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Retinoblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Cataract Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Ophthalmology
| Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Allergic Conditions, Drug Discovery, Clinical Trial
| Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Optic Neuritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Respiratory/Pulmonary
| Asthma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Asthma, Drug Discovery, Clinical Trial
| Stroke Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial, Cardiovascular
| Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Behcet Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Retinoic Acid Receptor Gamma (RAR Gamma or Nuclear Receptor Subfamily 1 Group B Member 3 or NR1B3 or RARG) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery, Clinical Trial
| Matrix Metalloproteinase 9 (Gelatinase B or 92 kDa Type IV Collagenase or 92 kDa Gelatinase or MMP9 or EC 3.4.24.35) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Drug Discovery, Clinical Trial
| Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Cancer Treatment, Drug Discovery, Clinical Trial, Oncology/Hematology
| Global Next Generation Antibody Therapeutics Market Insights and Forecast to 2028
Topics: Antibody Technologies, Drug Discovery
Regions: Global
| Sickle Cell Disease with Vaso-Occlusive Crisis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Discovery
| Parkinson's Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Topics: Drug Development, Parkinson's Disease, Research & Development, Drug Discovery
|
Prev | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | Next
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 350 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
|
